Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses
International Immunology · 01.09.2016 · 28 (9) · 423-433
DOI: 10.1093/intimm/dxw007 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, online erschienen am 19.02.2016. Verfasst von Yu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Mia…. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
B lymphocytes play a role in inhibiting the immune response against certain tumors, but the underlying mechanisms are poorly understood. EMT-6 mammary tumors grow well in wild-type (WT) mice but show reduced growth in B-cell-deficient μ−/− BALB/c mice (BCDM). WT mice demonstrate extensive B-cell infiltration into the tumor bed, reduced CD8+ T cell and CD49+ NK cell infiltration, and markedly reduced cytolytic T-cell response relative to BCDM. Expression of LAP/TGF-β1, CD80, CD86 and PD-L1 is significantly increased in tumor-infiltrating B cells (TIL-B) relative to splenic B cells. LAP/TGF-β1 expression on TIL-B progressively increased from 5.4±1.7% on day 8 to 43.1±6.1% by day 21 post tumor implantation. Co-culture of EMT-6 tumor cells with Naive-B cells ex vivo generated B cells (EMT6-B) with a similar immunophenotype to TIL-B. Purified TIL-B, or in-vitro-generated EMT6-B suppressed CD4+, CD8+ and CD4+CD25− T-cell proliferation, and Th1 cytokine secretion, and also suppressed purified NK-cell proliferation in response to IL-15, compared to naive splenic B cells. Acquired B regulatory function required direct tumor cell: B-cell contact, and was partially reversed by antibody to TGF-β or PD-L1, leading to tumor rejection in vivo. B-cell acquisition of a suppressive phenotype following tumor infiltration may result in profound inhibition of T-cell anti-tumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA y.zhang4@med.miami.edu.
- Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.
- Department of Immunology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Zhang, Y., Morgan, R., Chen, C., Cai, Y., Clark, E., Khan, W. N., Shin, S. U., Cho, H. M., Al Bayati, A., Pimentel, A., & Rosenblatt, J. D. (2016). Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses. International Immunology, 28(9), 423-433. https://doi.org/10.1093/intimm/dxw007
Vancouver
Zhang Y, Morgan R, Chen C, Cai Y, Clark E, Khan WN, et al. Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses. International Immunology. 2016;28(9):423-433. doi:10.1093/intimm/dxw007
BibTeX
@article{Zhang2016,
author = {Zhang, Yu and Morgan, Richard and Chen, Chuan and Cai, Yancheng and Clark, Emily and Khan, Wasif Noor and Shin, Seung-Uon and Cho, Hyun-Mi and Al Bayati, Ahmed and Pimentel, Augustin and Rosenblatt, Joseph D},
title = {Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses},
journal = {International Immunology},
year = {2016},
volume = {28},
number = {9},
pages = {423--433},
doi = {10.1093/intimm/dxw007}
}
EUVIMED